CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-28 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +70,300 | 70,300 | ||
| 2025-09-04 | Wan Jerry Principal Accounting Officer | Exercise or conversion | +34,100 | 46,764 | ||
| 2025-09-04 | Wan Jerry Principal Accounting Officer | Sale | −14,070 | $2.77 | $39K | 32,694 |
| 2025-09-04 | Wan Jerry Principal Accounting Officer | Exercise or conversion · Performance Restricted Stock Unit (PRSU) | −24,500 | 0 | ||
| 2025-09-04 | Wan Jerry Principal Accounting Officer | Exercise or conversion · Performance Restricted Stock Unit (PRSU) | −9,600 | 38,400 | ||
| 2025-01-28 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +48,000 | 48,000 | ||
| 2024-08-16 | Wan Jerry Principal Accounting Officer | Grant or award | +2,857 | $3.67 | $10K | 12,664 |
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Exercise or conversion | +5,625 | 12,057 | ||
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −2,250 | $4.51 | $10K | 9,807 |
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Exercise or conversion · Performance Restricted Stock Unit (PRSU) | −5,625 | 0 | ||
| 2024-01-22 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +24,500 | 24,500 | ||
| 2024-01-22 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Exercise or conversion | +1,250 | 7,101 | ||
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −669 | $8.29 | $6K | 6,432 |
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Exercise or conversion · Performance Restricted Stock Unit (PRSU) | −1,250 | 0 | ||
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Exercise or conversion | +5,625 | 8,861 | ||
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −3,010 | $6.80 | $20K | 5,851 |
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Exercise or conversion · Performance Restricted Stock Unit (PRSU) | +5,625 | 5,625 | ||
| 2023-01-25 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +15,000 | 15,000 | ||
| 2023-01-25 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 1 of 2 · 30 trades